Pre-market · Oct 6, 7:30 am ET · After hours $16.52 0.00%
Open$16.47
Prev close$16.40
Day range$16.17 – $16.72
Volume1.66M
Market cap$1.31B
P/E (TTM)26.6
Dividend yield–
EYE Stock News
Headlines matching National Vision or the EYE ticker, most recent first.
Needs Well: Neezwell strengthens its IT infrastructure modernization services with an eye toward the AI era.JPX · 8 Sep 2026
China Merchants Securities International: Humanoid robots enter mass delivery phase; supply chain shifts toward platformization and modularity. Keep an eye on Ubtech Robotics (09880) and others.Zhitong Finance · 30 Sep 2026
ANI Pharmaceuticals To Present Data From SYNCHRONICITY Phase 4 Clinical Trial Of Fluocinolone Acetonide Intravitreal Implant In Patients With Chronic Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye In Oral Presentation During Uveitis...Benzinga · 30 Sep 2026
On September 30, Chaoju Eye Care (02219) repurchased 36,500 shares for HK$88,200.Zhitong Finance · 30 Sep 2026
Shanghai Harbor (605598): Short-term profit margins under pressure; keep an eye on developments in the commercial space sector.Huatai Securities · 3 Sep 2026
Needs Well: Promoting the development of data‑driven talent with an eye toward the AI era.JPX · 29 Sep 2026
Aier Eye Hospital: Legal Opinion of Hunan Qiyuan Law Firm Regarding the First Extraordinary Shareholders' Meeting of Aier Eye Hospital Group Co., Ltd. for 2026SZSI · 15 Sep 2026
Xingqi Eye Medicine: Legal Opinion of King & Wood Mallesons Beijing on the Second Extraordinary Shareholders' Meeting of Shenyang Xingqi Eye Medicine Co., Ltd. for 2026SZSI · 14 Sep 2026
Guggenheim Maintains National Vision(EYE.US) With Buy Rating, Cuts Target Price to $27Market news · 11 Sep 2026
Barclays Maintains National Vision(EYE.US) With Buy Rating, Maintains Target Price $27Market news · 10 Sep 2026
Cat Eye Entertainment (01896.HK): Film business under short-term pressure; summer box-office season showing signs of recovery; IP business expanding steadily.Western Securities · 1 Sep 2026
TopCloudAg (301556): Project timelines are weighing on near-term revenue; keep an eye on opportunities arising from business model evolution.CICC · 28 Aug 2026
Aier Eye Hospital (300015): Earnings in the first half of 2026 are expected to be volatile, with the refractive surgery business posting rapid growth.开源证券 · 28 Aug 2026
Aier Eye Hospital (300015): Revenue in 26H1 grew steadily, with outpatient visits and surgical procedures continuing to rise.Guosen Securities · 28 Aug 2026
Discussion
No comments yet — be the first to weigh in on EYE.
No comments yet — be the first to weigh in on EYE.